Page last updated: 2024-08-16

ribavirin and Anemia, Sickle Cell

ribavirin has been researched along with Anemia, Sickle Cell in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (66.67)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El Agheb, MO; Grange, JD1
Amiot, X; Ancel, D; Chaslin-Ferbus, D; Garioud, A; Girot, R; Grange, JD; Hagege, I; Pol, S1
Abbas, FA; Ayyub, MA; El-Moursy, SA; Khazindar, AM1
Alavian, SM; Ayyub, M; Tabatabaei, SV1
Alavian, SM; Tabatabaei, SV1
Inati, A; Musallam, KM; Sharara, AI; Taher, AT1
Banks, A; Castro, O; Giday, S; Hasan, S; Hassan, M; Smoot, D1
Smoot, DT1
Agarwal, S; Rosse, WF; Swaim, MW1

Reviews

1 review(s) available for ribavirin and Anemia, Sickle Cell

ArticleYear
HCV in sickle cell disease.
    Journal of the National Medical Association, 2003, Volume: 95, Issue:9

    Topics: Anemia, Sickle Cell; Antiviral Agents; Chronic Disease; Comorbidity; Disease Progression; Genotype; Hepacivirus; Hepatitis C; Humans; Interferons; Liver; Prevalence; Ribavirin; Transfusion Reaction; United States

2003

Other Studies

8 other study(ies) available for ribavirin and Anemia, Sickle Cell

ArticleYear
[Evaluation of tolerance and efficacy of the treatment of chronic viral hepatitis C in homozygous sickle cell patients].
    The Pan African medical journal, 2015, Volume: 20

    Topics: Adult; Anemia, Sickle Cell; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Ribavirin; Treatment Outcome

2015
Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin.
    European journal of gastroenterology & hepatology, 2009, Volume: 21, Issue:7

    Topics: Adolescent; Adult; Anemia, Hemolytic; Anemia, Sickle Cell; Antiviral Agents; beta-Thalassemia; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Male; Pilot Projects; Ribavirin; Treatment Outcome; Young Adult

2009
Successful treatment of chronic hepatitis C virus infection with peginterferon alpha-2a and ribavirin in patients with sickle cell disease.
    Saudi medical journal, 2009, Volume: 30, Issue:5

    Topics: Adolescent; Adult; Anemia, Sickle Cell; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Young Adult

2009
Outcome of combination antiviral therapy in hepatitis C virus infected patients with sickle cell disease.
    Saudi medical journal, 2009, Volume: 30, Issue:8

    Topics: Anemia, Sickle Cell; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin

2009
Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin.
    European journal of gastroenterology & hepatology, 2010, Volume: 22, Issue:1

    Topics: Anemia, Sickle Cell; Antiviral Agents; beta-Thalassemia; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferons; Ribavirin; Treatment Outcome

2010
The role of liver iron in hepatitis C antiviral treatment.
    European journal of gastroenterology & hepatology, 2010, Volume: 22, Issue:6

    Topics: Anemia, Sickle Cell; Antiviral Agents; beta-Thalassemia; Blood Transfusion; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Iron; Liver; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2010
Response to "Hepatitis C virus, sickle cell disease treatment options"--a February letter to the editor.
    Journal of the National Medical Association, 2004, Volume: 96, Issue:3

    Topics: Anemia, Sickle Cell; Antiviral Agents; Comorbidity; Hepatitis C; Humans; Interferons; Iron Chelating Agents; Ribavirin

2004
Successful treatment of hepatitis C in sickle-cell disease.
    Annals of internal medicine, 2000, Nov-07, Volume: 133, Issue:9

    Topics: Adult; Anemia, Sickle Cell; Antisickling Agents; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Hydroxyurea; Interferon alpha-2; Interferon-alpha; Middle Aged; Recombinant Proteins; Ribavirin

2000